Consumer demand can accelerate production or shipment priorities
GLP-1 as a trend has grown by 1054% in social discussion over the past year, according to Tastewise, a GenAI-powered consumer data platform (see graph below)
With the use of Semaglutide GLP-1 injection, we can provide long-term solutions for type 2 diabetes and obesity management
You can also skip the beans for that meal and add them back another day
Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions Patients who have plateaued on a single-agonist GLP-1 and want to escalate under supervision Members for whom faster onset and higher trial averages are clinically appropriate Personal or family history of medullary thyroid carcinoma or MEN 2 Pregnancy, breastfeeding, or planning pregnancy Active pancreatitis or untreated severe gastrointestinal disease IIIExpected Timeline What to Expect Tirzepatide tends to act faster and reach further than single-agonist GLP-1s
This is the first large study the authors could find that puts the question to a systematic test, using health records from Penn Medicine, an academic system covering more than 6.5 million patients around Philadelphia, Delaware, and southern New Jersey